The Japanese biopharmacy company Takeda reached in October an agreement with Moderna and the Japanese Ministry of Health, Labour and Welfare to distribute 50 million doses during the first half of 2021 under the TAK-919 name. On 21 May 2021, Takeda announced the approval of the formula by the Japanese Government, and informed that the distribution would immediately start.

Read all the information about Moderna’s vaccine here.

We are a team of young journalists from Barcelona who work independently to combat misinformation in our territory and beyond. We rely on facts and data to verify what politicians say and the falsehoods circulating on social media.

We need you. With your contribution, you will contribute to a healthier political debate and help promote educational projects to teach citizens how to navigate information chaos and defend themselves against misinformation.

You can contribute as much as one euro and it won't take you more than 45 seconds (we've counted them). If you can, please mark your contribution as monthly and so we can continue to do our job rigorously and independently. Thank you so much.